Search results
Results from the WOW.Com Content Network
In June 2007, a private equity firm, Cerberus Capital Management, acquired Remington Arms for $370 million, including $252 million in assumed debt. It became part of the company's Freedom Group. Remington was millions of dollars in debt and did not report a profit from 2003 to 2005. [3] In 2015, the Freedom Group was renamed Remington Outdoor ...
Parent company Remington Outdoor Company filed for Chapter 11 bankruptcy protection in March 2018. [4] As a result of the bankruptcy auction, the company was sold to JJE Capital Holdings, LLC in September 2020. [5] [better source needed] JJE Capital Holdings, which also owns Palmetto State Armory, [6] integrated AAC into its portfolio. This ...
American Capital was sold to Ares Management in 2017 at a sale price that totaled $4.1 billion. For those investors who bought American Capital stock in its August 29, 1997 IPO, and held their shares through the sale of American Capital on January 3, 2017, they received a 14% compounded annual return including dividends (not reinvested).
In terms of valuation, Merck stock is trading at a forward price-to-earnings (P/E) ratio of 14, which is near a peer-group average of 15 among pharmaceutical leaders like Johnson & Johnson, Pfizer ...
Science & Tech. Shopping. Sports
Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S&P 500. Why isn't Merck's stock doing better in ...
Remington Arms was a notable American manufacturer of firearms, founded in 1816 by Eliphalet Remington and originally known as E. Remington and Sons. The company was acquired in June 2007 by a private equity firm, Cerberus Capital Management. [2] It became part of the firm's Freedom Group, which was renamed in 2015 as Remington Outdoor Company ...
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports Q3 earnings.